We value openness, integrity, transparency and positive intent. We respect individual talent and contribution
We strive to be proactive in understanding our client’s objectives and achieving them effectively.
We thrive in an environment that is innovative and not burdened by excessive layers of decision making.
We are only here because we believe in working together for the greater good of humanity. This passion drives us forward everyday.
Collaboration they say is the new competition. Through collaboration, we provide our clients with the assurance and confidence that their compliance activities are at the forefront of industry best practices.
Our state-of-the-art eQMS solutions streamline our Quality Assurance process, from planning and execution to reporting and follow-up. By integrating eQMS into your operations
Our highly experienced, trained and competent team of specialist GCP auditors has conducted thousands of audits in all therapeutic areas, according to international and national regulations, in over 100 countries. Continual positive client feedback is evidence of our professionalism and competency.
We place significant emphasis on adding value to the GVP service we provide to our clients. In response to global regulatory requirements, industry trends and our clients’ needs we are continuously developing our service offerings to ensure we remain at the leading edge of GVP consultancy services worldwide.,
We work to evaluate systems at your pharmaceutical, biotechnology, and medical device organization or at your vendor sites to determine if the systems in place are sufficient to meet your manufacturing needs and the current regulatory standards.
Our team of experts brings a wealth of experience and a deep understanding of regulatory requirements to help you navigate the complexities of compliance, ensuring your operations meet the stringent standards required by regulatory authorities.
In 2024, the landscape of clinical research organizations (CROs) is more dynamic than ever, with companies pushing the boundaries of innovation, quality, and efficiency in clinical trials. Among the
